Top

memo - Magazine of European Medical Oncology

Published in:

01-09-2018 | editorial

Cure in metastatic disease

Author: Dr. Hannes Kaufmann

Published in: memo - Magazine of European Medical Oncology | Issue 3/2018

Excerpt

One of the principles in oncology over decades was that patients diagnosed with metastatic cancer were unlikely to be cured of their disease by any means. At best, treatment with classical chemotherapy ended in extended progression-free or overall survival. Complete remissions from systemic standard chemotherapy are uncommon, and only a fraction of complete responders remain progression free for a prolonged period in most malignant diseases. …

Daneshmand S, Albers P, Fosså SD, et al. Contemporary management of postchemotherapy testis cancer. Eur Urol. 2012;62(5):867–76.CrossRefPubMed

Jamison RL, Donohue JH, Nagorney DM, Rosen CB, Harmsen WS, Ilstrup DM. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg. 1997;132(5):505–11. https://doi.org/10.1001/archsurg.1997.CrossRefPubMed

Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13:8–10.CrossRefPubMed

Corbin KS, Hellman S, Weichselbaum RR. Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy. J Clin Oncol. 2013;31:1384–90.CrossRefPubMed

Tohme S, Simmons RL, Tsung A. Surgery for cancer: a trigger for metastases. Cancer Res. 2017;77(7):1548–52. https://doi.org/10.1158/0008-5472.CAN-16-1536.CrossRefPubMedPubMedCentral

Title: Cure in metastatic disease
Author: Dr. Hannes Kaufmann
Publication date: 01-09-2018
Publisher: Springer Vienna
Published in: memo - Magazine of European Medical Oncology / Issue 3/2018
Print ISSN: 1865-5041
Electronic ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-018-0423-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2018

Cure in metastatic breast cancer

Still making progress

Demystification of palliative care: what palliative care teams don’t want you to think about them

Nonmalignant hematology

SABCS 2017: update on chemotherapy, targeted therapy, and immunotherapy

SABCS 2017: lifestyle factors, hormone receptor-positive advanced disease, liquid biopsies, and prognosis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer